Literature DB >> 16940870

Hepatitis E indigenous to economically developed countries: to what extent a zoonosis?

Chong Gee Teo1.   

Abstract

PURPOSE OF REVIEW: Hepatitis E, a disease transmitted by hepatitis E virus, is increasingly recognized as being indigenous to affluent, temperate-zone countries. Issues pertaining to disease acquisition and hepatitis E virus infection, particularly in Western countries, are reviewed and highlighted. RECENT
FINDINGS: Clinical hepatitis E in the West, as in Japan, manifests more commonly in older people (>60 years) and in men, but fulminant hepatitis appears less frequent than in Japan. There, specific gastronomic and culinary risk factors associated with disease are being identified, but in the West, data implicating hepatitis E as being foodborne have yet to emerge. While hepatitis E virus subgenomic sequences in Western case patients are found to be closely related to swine hepatitis E virus, a porcine linkage to their infection remains to be established. Weak associations between occupational contact with pigs and risk of infection have been noted. Findings from earlier studies implicating animals that cohabitate with humans as reservoirs, and sewage as vehicles of infection await confirmation.
SUMMARY: Hepatitis E indigenous to developed countries is a distinct clinico-epidemiological entity. Humans, animals, food and the environment contribute and interact to cause human disease, and to sustain hepatitis E virus endemicity and enzooticity.

Entities:  

Mesh:

Year:  2006        PMID: 16940870     DOI: 10.1097/01.qco.0000244052.61629.49

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  13 in total

1.  Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.

Authors:  Peer B Christensen; Ronald E Engle; Charlotte Hjort; Keld M Homburg; Werner Vach; Jørgen Georgsen; Robert H Purcell
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

2.  Fulminant hepatitis E in a woman taking oral contraceptive medication.

Authors:  Maria Luisa Mateos Lindemann; Javier Graus Morales; Salceda Fernández-Barredo; Mario Rodríguez Domínguez; Fernando García de la Hoz; Philippe Halfon; Maria Teresa Pérez Gracia
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

3.  Evolutionary history and population dynamics of hepatitis E virus.

Authors:  Michael A Purdy; Yury E Khudyakov
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

4.  Hepatitis E: a complex and global disease.

Authors:  E Pelosi; I Clarke
Journal:  Emerg Health Threats J       Date:  2008-11-07

5.  Hepatitis E virus in England and Wales: indigenous infection is associated with the consumption of processed pork products.

Authors:  B Said; S Ijaz; M A Chand; G Kafatos; R Tedder; D Morgan
Journal:  Epidemiol Infect       Date:  2013-09-20       Impact factor: 4.434

6.  Hepatitis E outbreak on cruise ship.

Authors:  Bengü Said; Samreen Ijaz; George Kafatos; Linda Booth; H Lucy Thomas; Amanda Walsh; Mary Ramsay; Dilys Morgan
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

7.  Hepatitis E virus infection in sheltered homeless persons, France.

Authors:  Mamadou Kaba; Philippe Brouqui; Hervé Richet; Sekené Badiaga; Pierre Gallian; Didier Raoult; Philippe Colson
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

8.  Hepatitis E in England and Wales.

Authors:  Hannah C Lewis; Sophie Boisson; Samreen Ijaz; Kirsten Hewitt; Siew Lin Ngui; Elizabeth Boxall; Chong Gee Teo; Dilys Morgan
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

9.  Transmission dynamics of hepatitis E among swine: potential impact upon human infection.

Authors:  Kunio Satou; Hiroshi Nishiura
Journal:  BMC Vet Res       Date:  2007-05-10       Impact factor: 2.741

10.  Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004 - 2006.

Authors:  Katrine Borgen; Tineke Herremans; Erwin Duizer; Harry Vennema; Saskia Rutjes; Arnold Bosman; Ana Maria de Roda Husman; Marion Koopmans
Journal:  BMC Infect Dis       Date:  2008-05-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.